Clinical trials
Lung Diseases, Interstitial trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 3 |
| 2020 | 1 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 7 |
| Recruiting | 6 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 5 |
| Bristol-Myers Squibb | 2 |
| Maastricht University | 2 |
| Maastricht University Medical Center | 2 |
| United Therapeutics | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Amsterdam UMC, location VUmc | 1 |
| AstraZeneca | 1 |
| Avalyn Pharma Inc. | 1 |
| Erasmus Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 30 |
| Idiopathic Pulmonary Fibrosis | 9 |
| Pulmonary Fibrosis | 6 |
| Sarcoidosis | 5 |
| Fibrosis | 4 |
| Scleroderma, Diffuse | 4 |
| Autoimmune Diseases | 3 |
| Inflammation | 3 |
| Arthritis, Rheumatoid | 2 |
| Connective Tissue Diseases | 2 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.